IL91217A0 - Pharmaceutical compositions for treating or preventing schizophrenia and/or psychosis containing quinuclidine derivatives - Google Patents

Pharmaceutical compositions for treating or preventing schizophrenia and/or psychosis containing quinuclidine derivatives

Info

Publication number
IL91217A0
IL91217A0 IL91217A IL9121789A IL91217A0 IL 91217 A0 IL91217 A0 IL 91217A0 IL 91217 A IL91217 A IL 91217A IL 9121789 A IL9121789 A IL 9121789A IL 91217 A0 IL91217 A0 IL 91217A0
Authority
IL
Israel
Prior art keywords
chem
general formula
psychosis
treating
pharmaceutical compositions
Prior art date
Application number
IL91217A
Other languages
English (en)
Original Assignee
Robins Co Inc A H
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H, Delalande Sa filed Critical Robins Co Inc A H
Priority to IL91217A priority Critical patent/IL91217A0/xx
Publication of IL91217A0 publication Critical patent/IL91217A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL91217A 1988-08-04 1989-08-04 Pharmaceutical compositions for treating or preventing schizophrenia and/or psychosis containing quinuclidine derivatives IL91217A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL91217A IL91217A0 (en) 1988-08-04 1989-08-04 Pharmaceutical compositions for treating or preventing schizophrenia and/or psychosis containing quinuclidine derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88402042A EP0353372B1 (en) 1988-08-04 1988-08-04 Antischizophrenic-S-N-(1-azabicyclo[2.2.2.]oct-3-yl) benzamides and thiobenzamides
IL91217A IL91217A0 (en) 1988-08-04 1989-08-04 Pharmaceutical compositions for treating or preventing schizophrenia and/or psychosis containing quinuclidine derivatives

Publications (1)

Publication Number Publication Date
IL91217A0 true IL91217A0 (en) 1990-07-12

Family

ID=8200415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91217A IL91217A0 (en) 1988-08-04 1989-08-04 Pharmaceutical compositions for treating or preventing schizophrenia and/or psychosis containing quinuclidine derivatives

Country Status (11)

Country Link
US (1) US5025022A (ja)
EP (1) EP0353372B1 (ja)
JP (1) JPH02104529A (ja)
KR (1) KR900002777A (ja)
AT (1) ATE85217T1 (ja)
AU (1) AU615323B2 (ja)
DE (1) DE3878235T2 (ja)
DK (1) DK382089A (ja)
IL (1) IL91217A0 (ja)
PH (1) PH25426A (ja)
ZA (1) ZA895842B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353371A1 (en) * 1988-08-04 1990-02-07 Synthelabo Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
JP2004506735A (ja) 2000-08-18 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用キヌクリジン置換アリール化合物
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001282873A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6500840B2 (en) 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
JP2005504059A (ja) * 2001-08-24 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 疾患を処置するための置換アリール７−アザ［２．２．１］ビシクロヘプタン
EP1442041A1 (en) * 2001-11-08 2004-08-04 PHARMACIA & UPJOHN COMPANY Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
CA2476417A1 (en) 2002-02-15 2003-08-28 Pharmacia & Upjohn Company Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
EP1478646A1 (en) * 2002-02-20 2004-11-24 PHARMACIA & UPJOHN COMPANY Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
WO2004013137A1 (en) 2002-08-01 2004-02-12 Pharmacia & Upjohn Company Llc 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
GB0310867D0 (en) 2003-05-12 2003-06-18 Novartis Ag Organic compounds
US8435762B2 (en) 2008-10-09 2013-05-07 Howard Hughes Medical Institute Chimeric ligand-gated ion channels and methods of use thereof
JOP20130273B1 (ar) 2012-09-11 2021-08-17 Genzyme Corp مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
CN104418851A (zh) * 2013-09-02 2015-03-18 上海龙翔生物医药开发有限公司 奎宁环衍生物的制备方法及纯化方法
CN115427038A (zh) 2020-02-03 2022-12-02 建新公司 治疗与溶酶体贮积病相关的神经系统症状的方法
BR112023000798A2 (pt) 2020-07-24 2023-02-07 Genzyme Corp Composições farmacêuticas compreendendo venglustat

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
GB8515845D0 (en) * 1985-06-22 1985-07-24 Beecham Group Plc Treatment
EP0235878A3 (en) * 1986-01-16 1989-06-14 Beecham Group Plc Novel compounds
PH23937A (en) * 1986-12-16 1990-01-23 Robins Co Inc A H Anxiolytic-n-(1-azabicyclo(2.2.2.)oct-3-yl)benzamides and thiobenzamides
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
US4857517A (en) * 1988-02-04 1989-08-15 Rorer Pharmaceutical Corporation Quinuclidyl benzoxepins as 5-HT3 antagonists
EP0353371A1 (en) * 1988-08-04 1990-02-07 Synthelabo Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides

Also Published As

Publication number Publication date
DK382089A (da) 1990-02-05
DK382089D0 (da) 1989-08-03
JPH02104529A (ja) 1990-04-17
PH25426A (en) 1991-07-01
ZA895842B (en) 1991-03-27
EP0353372B1 (en) 1993-02-03
KR900002777A (ko) 1990-03-23
EP0353372A1 (en) 1990-02-07
DE3878235D1 (de) 1993-03-18
DE3878235T2 (de) 1993-06-03
AU3917889A (en) 1990-02-08
US5025022A (en) 1991-06-18
ATE85217T1 (de) 1993-02-15
AU615323B2 (en) 1991-09-26

Similar Documents

Publication Publication Date Title
IL91217A0 (en) Pharmaceutical compositions for treating or preventing schizophrenia and/or psychosis containing quinuclidine derivatives
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
NZ232283A (en) Substituted imidazo(1,2-b)pyridazine derivatives; pharmaceutical compositions and preparatory processes
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
HK123595A (en) Thiazolidinone and oxazolidinone derivatives their preparation and their use as vasodilators
AU7624494A (en) Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
PH25911A (en) New cephem compounds pharmaceutical composition containing said compounds and method of use thereof
ATE48999T1 (de) Piperazin-1-yl-ergolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IL89942A (en) Heterotetracyclic lactam derivatives, their preparation and pharmaceutical compositions containing them
DE3065469D1 (en) Triazolo (4,3-a)pyridin-3(2h)-ones, process for their preparation and pharmaceutical compositions containing them
PT85378A (en) Process for the preparation of new tetracyclic indole derivatives and of pharmaceutical compositions containing the same
ATE115582T1 (de) Cephalosporinderivate.
IL86795A0 (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
AU586089B2 (en) Phosphodiesterace type 111 inhibitors having a thiadiazinone ring as part of a tricyclic structure